This guidance has been produced by a multidisciplinary working party on behalf of the UK Chemotherapy Board which includes specialist representation from medical, dental and nursing teams across the UK.
The RCP's consultation response to the House of Commons Science and Technology Committee 2015 inquiry looking at the opportunities and risks of 'big data'.